Kieger is the independent asset manager designing solutions for caring and purposeful investors dedicated to creating a sustainable future.
Designing tailor-made asset management solutions for more than 20 years
Specialised in listed equity healthcare, private equity and multi-asset investments
Based in Zurich, Switzerland, regulated by FINMA
We care about your beliefs, your convictions and how you want your assets to make a positive difference on the future of our world. You can trust our dedication. With 20 years’ experience in helping investors address complex situations, we know what it means to serve clients who place a premium on the service and attention received. We call it “dare to care”.
Harness our 20 years of specialised healthcare investing experience to benefit from the long-term growth of this defensive sector. Invest sustainably and, if you wish, choose to invest with impact.
Capitalise on the high growth potential of companies led by entrepreneurial teams operating in sectors undergoing secular evolutions.
Access to a broad investment universe and diversified portfolio construction for investment success. Original ideas combined with sophisticated asset allocation help you achieve your goals with confidence.
Our ambition is to help you make a positive difference: for future generations and your return through the excellence in the management of your assets.
As a focused, independent organisation, our ESG analysis is pure, not conflicted with any other business nor challenged by size and capacity.
We conduct our own thoughtful ESG assessment and do not rely solely on external research.
We use numerous data sources as a basis for analysis. Each decision is assessed at multiple levels (analysts, sustainability & impact committee).
We evaluate both the ESG factors and their real-world impacts.
Latest news from our team, empowering your financial decisions.
Energy is the word on everyone 8217 s lips from AI to cryptocurrencies to geopolitics However energy is also crucial to our health and could be the key to understanding neurodegenerative diseases like Alzheimer 8217 s
Find out
Companies are innovating across the spectrum new modalities targets and insights in disease biology This progress is close to academia and at the leading edge of research Discover what investment opportunities this unveils in our Thoughts from the Street about
Watch our first quarterly call about the impact on patient outcomes through sustainable healthcare practices
Get a regular dose of our insightful updates: from our Thoughts from the Street, to Healthcare Commentary, and more.
Take the first step in making a positive difference:
our dedicated team is here to assist you.
